Clayton Edward Strong, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |
Anjan P Kaushik, Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, New Castle, IN 47362 Phone: 765-521-7385 |
Dr. Kyle William Siewert, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite 240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |
Dr. Lindsey R Rolston, M.D Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |
Dr. Thomas J. Mathews, M.D Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |
Dr. Damion M. Harris, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2200 Forest Ridge Pkwy, Suite #240, New Castle, IN 47362 Phone: 765-521-7385 Fax: 765-521-7394 |
News Archive
Delegates from more than 120 countries met this week to continue constructing a legally-binding global mercury treaty, expected to be signed in Minamata, Japan in 2013. While many important issues were discussed, public interest NGOs urged delegates to be more ambitious when setting the mercury treaty's scope and goals.
Drinking 3-5 cups of coffee per day may help to protect against Alzheimer's Disease, according to research highlighted in an Alzheimer Europe session report published by the Institute for Scientific Information on Coffee, a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health.
Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.
ACT Biotech, a biopharmaceutical company focused on the development of highly targeted, oral therapeutics for the treatment of cancer, today released data on additional analysis of the Phase 2 clinical trial of telatinib in patients with metastatic stomach cancer that further supports the highly-potent nature of the antiangiogenic agent.
Scientists at Scripps Research have found that they can reverse the desire to drink in alcohol-dependent rats-with the flip of a switch.
› Verified 9 days ago